Pneumococcal Vaccines Market is Estimated to Witness High Growth Owing to Increasing Prevalence of Pneumococcal Diseases.
The pneumococcal vaccines market has witnessed significant growth over the past few years owing to the increasing prevalence of pneumococcal diseases. Pneumococcal disease is a bacterial infection caused by Streptococcus pneumoniae and is a leading cause of childhood morbidity and mortality worldwide. Pneumococcal vaccines help prevent pneumococcal pneumonia, meningitis, and other invasive pneumococcal diseases. The two main types of pneumococcal vaccines available in the market are pneumococcal conjugate vaccines (PCVs) and pneumococcal polysaccharide vaccines (PPSVs). PCVs provide protection for infants and young children, while PPSVs are recommended for older children and adults.
Global pneumococcal vaccines market is estimated to be valued at USD 9.38 billion in 2025 and is expected to reach USD 13.29 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.1% from 2025 to 2032.
Key Takeaways
Key players operating in the Pneumococcal Vaccines Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc (GSK), Sanofi, CSL Limited, Serum Institute of India Pvt. Ltd., Vaxcyte, Inc., Astellas Pharma Inc., Panacea Biotec Ltd., Walvax Biotechnology Co., Ltd., Beijing Minhai Biotechnology Co., Ltd., Merck KGaA, Takeda Pharmaceutical Company Limited, AbbVie Inc., Novartis AG, Johnson & Johnson, Biovac, Bharat Biotech, Inovio Pharmaceuticals, Inc., Hilleman Laboratories Pvt. Ltd.
The Pneumococcal Vaccines Market Demand is set to grow significantly, driven by increasing vaccination rates in developing countries and the development of newer, expanded valent vaccines.
Moreover, with rising awareness about pneumococcal diseases, major players are focusing on expanding their geographic presence by collaborating with regional vaccine manufacturers to strengthen product distribution networks globally.
Market Drivers
Increasing government initiatives toward immunization programs is a key factor driving the growth of the pneumococcal vaccines market. Many developing and underdeveloped countries are actively working with global health bodies like WHO and UNICEF to enhance vaccination coverage. For instance, the national immunization program by the Government of India has included PCV13 vaccination in the routine immunization schedule from 2017. Extensive support from global health organizations as well as governments worldwide has a positive impact on pneumococcal vaccination uptake, thereby boosting market revenue.
PEST Analysis
Political: Vaccinations are mandatory in some countries which helps increase the sales of vaccines. Certain regulations passed by governments also impact the demand for vaccines.
Economic: Changes in GDP, per capita income affect spending on healthcare products. Recovery of economies post covid increases healthcare budgets which boost spending on vaccines.
Social: Growing health awareness among public increases focus on preventive healthcare through vaccination drives. Social media influences opinions which can affect vaccination programs.
Technological: Advances in vaccine production technologies help lower costs and improve efficacy. Technologies like blockchain are being implemented to ensure vaccine security and traceability in supply chains.
Value Concentration by Regions
The North American region holds a major share of the global pneumococcal vaccines market in terms of value. Higher per capita income and developed healthcare infrastructure helps sustain sales in the US and Canada. Medical reimbursements for recommended vaccines increase affordability in the region.
Fastest Growing Region
The Asia Pacific region is expected to grow at the fastest rate for the pneumococcal vaccines market during the forecast period. Rising awareness about vaccine-preventable diseases, establishment of national immunization programs, and expansion of healthcare systems will drive market growth in countries like India and China which have large populations.
Get This Report in Japanese Language -肺炎球菌ワクチン市場
Get This Report in Korean Language -폐렴구균 백신 시장
About Author:
Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement.
(LinkedIn- https://www.linkedin.com/in/priya-pandey-8417a8173/)